Giuseppe Borzacchiello Selected Research

Infections

1/2022	Expression of matrix metalloproteinases (MMPs)-2/-7/-9/-14 and tissue inhibitors of MMPs (TIMPs)-1/-2 in bovine cutaneous fibropapillomas associated with BPV-2 infection.
12/2020	Detection of Felis catus papillomavirus type-2 DNA and viral gene expression suggest active infection in feline oral squamous cell carcinoma.
1/2020	Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection.
10/2013	Pour-on alphacypermethrin is an effective treatment for natural Werneckiella equi infection in donkeys (Equus asinus).
1/2012	Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors.
8/2011	PBMCs are additional sites of productive infection of bovine papillomavirus type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Borzacchiello Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 09/2007
6	Squamous Cell Carcinoma of Head and Neck 11/2023 - 01/2020
6	Infections 01/2022 - 08/2011
6	Carcinogenesis 01/2013 - 05/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 01/2016
2	Papillomavirus Infections 06/2016 - 01/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014 - 01/2012
2	Carcinoma (Carcinomatosis) 11/2012 - 03/2012
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Hypoxia (Hypoxemia) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2018
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Papilloma (Papillomatosis) 07/2013
1	Cystitis 06/2011
1	Limb-girdle muscular dystrophy type 2A 04/2010
1	Virus Diseases (Viral Diseases) 12/2008
1	Animal Mammary Neoplasms 09/2007

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2007
7	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 04/2010
7	Oncogene Proteins (Oncogene Protein)IBA 01/2014 - 05/2007
4	Matrix Metalloproteinases (MMPs)IBA 11/2023 - 01/2020
4	Platelet-Derived Growth FactorIBA 02/2017 - 03/2012
2	Cetuximab (Erbitux)FDA Link 11/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 11/2023 - 01/2022
2	Monoclonal AntibodiesIBA 11/2023 - 01/2022
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 01/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2017 - 01/2013
2	Capsid Proteins (Capsid Protein)IBA 01/2012 - 08/2011
1	Cytostatic AgentsIBA 11/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2022
1	Collagenases (Collagenase)FDA Link 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	ZincIBA 01/2020
1	BIBR 1532IBA 01/2020
1	EndopeptidasesIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Ligases (Synthetase)IBA 12/2018
1	UbiquitinIBA 12/2018
1	Apoptosis Regulatory ProteinsIBA 01/2015
1	Proton Pumps (Proton Pump)IBA 01/2014
1	Adenosine Triphosphatases (ATPase)IBA 01/2014
1	cypermethrin (alphamethrin)IBA 10/2013
1	phenethyl isothiocyanate (PEITC)IBA 07/2013
1	Imatinib Mesylate (Gleevec)FDA Link 01/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2012
1	GRB2 Adaptor ProteinIBA 03/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2012
1	Mitogen-Activated Protein KinasesIBA 03/2012
1	Viral DNAIBA 01/2012
1	EpitopesIBA 09/2011
1	Transcription Factors (Transcription Factor)IBA 04/2010
1	CalpainIBA 04/2010
1	Peptide Hydrolases (Proteases)FDA Link 04/2010
1	CarcinogensIBA 12/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2008
1	beta CateninIBA 09/2007
1	CateninsIBA 09/2007
1	Cadherins (E-Cadherin)IBA 09/2007

Therapy/Procedure

3	Therapeutics 11/2023 - 02/2017
1	Lasers (Laser) 09/2007